Value of CA 15:3 in the follow-up of breast cancer patients.
about
Application of carbon nanotubes layered on silicon wafer for the detection of breast cancer marker carbohydrate antigen 15-3 by immuno-polymerase chain reaction.Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer--a comparison with CA15.3.Elevated CA125 levels in patients with metastatic breast carcinoma.Comparative values of several tumour markers: example of untreated breast carcinoma.The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 casesAn evaluation of preoperative CA 15-3 measurement in primary breast carcinoma.Serum CA 15-3 assay in the diagnosis and follow-up of breast cancerCirculating CA 15-3 antigen levels in non-mammary malignancies.An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer.Clinical significance of serum CA15-3 as a prognostic parameter during follow-up periods in patients with breast cancer.Murine monoclonal antibodies in breast cancer: an overview.Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.Objective measurement of therapeutic response in breast cancer using tumour markers.Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon.Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer.
P2860
Q35002966-6D8C8AB6-2ACF-4F9A-83A9-57FEC91E805BQ35977830-00260FFD-426F-4C14-92CA-03401BE25C5FQ35982073-2665FCB3-7606-4A24-B5CA-A7806B568C9AQ35982275-CC0BE4BA-0BD3-472D-8EA3-59D580B9A59EQ35984390-A6ACF270-A7D5-4513-8A28-D79D8C68050BQ36081093-529B32BB-2B76-4674-A168-74B3A9CCDBD7Q36466612-D42CDA85-3B3D-46E2-92B9-069B3655EF5CQ36467062-AFF0806F-755A-4C4D-96A4-46F08546C101Q36467766-FFCFEEA2-5787-4597-8FCB-24D83CF81D24Q36573275-28669CE7-468F-421E-B57B-9EEEF520BB0AQ39551026-8C589701-E35F-436C-A832-B5EFE6E028D0Q41968752-1B2BD4A6-1EAE-40AE-AA78-B9D5CB1A7BF6Q42281537-F16D2520-DEE6-430B-AD33-FD08CE79357CQ44716081-E4F054E6-D84C-44E0-82BD-B45BEBDC816FQ45267139-91606E77-B6AD-40DF-B9AE-1693CDE572F0Q51750528-0EFF5DF1-8C63-4D9E-848F-A65AED7E7DEE
P2860
Value of CA 15:3 in the follow-up of breast cancer patients.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Value of CA 15:3 in the follow-up of breast cancer patients.
@ast
Value of CA 15:3 in the follow-up of breast cancer patients.
@en
type
label
Value of CA 15:3 in the follow-up of breast cancer patients.
@ast
Value of CA 15:3 in the follow-up of breast cancer patients.
@en
prefLabel
Value of CA 15:3 in the follow-up of breast cancer patients.
@ast
Value of CA 15:3 in the follow-up of breast cancer patients.
@en
P2093
P356
P1476
Value of CA 15:3 in the follow-up of breast cancer patients.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1987.115
P407
P577
1987-05-01T00:00:00Z